Onco-Primary Care of Patients Receiving Immune Checkpoint Inhibitors

Authors: Hoimes, Christopher J., McGettigan, Suzanne, Schwartzberg, Lee

Source: In The American Journal of Medicine December 2024 137(12):1200-1209

A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma

Authors: Msaouel, Pavlos, Sweis, Randy F., Bupathi, Manojkumar, Heath, Elisabeth, Goodman, Oscar B., Jr, Hoimes, Christopher J., Milowsky, Matthew I., Davis, Nancy, Kalebasty, Arash Rezazadeh, Picus, Joel, Shaffer, David, Mao, Shifeng, Adra, Nabil, Yorio, Jeffrey, Gandhi, Sunil, Grivas, Petros, Siefker-Radtke, Arlene, Yang, Rui, Latven, Lisa, Olson, Peter, Chin, Curtis D., Der-Torossian, Hirak, Mortazavi, Amir, Iyer, Gopa

Source: In European Urology Oncology August 2024 7(4):933-943

Assessing the utility of molecular diagnostic classification for cancers of unknown primary

Authors: Moore, Elle C., Blobe, Gerard C., DeVito, Nicholas C., Hanks, Brent A., Harrison, Michael R., Hoimes, Christopher J., Jia, Jingquan, Morse, Michael A., Jayaprakasan, Parvathy, MacKelfresh, Andrew, Mulder, Hillary, Hockenberry, Adam J., Zander, Alia, Stumpe, Martin C., Michuda, Jackson, Beauchamp, Kyle A., Perakslis, Eric, Taxter, Timothy, George, Daniel J.

Source: Cancer medicine. 12(19):19394-19405

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100196445683.0x000001&indx=1&recIds=ETOCvdc_100196445683.0x000001

Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma

Authors: Talukder, Rafee, Makrakis, Dimitrios, Lin, Genevieve Ihsiu, Diamantopoulos, Leonidas N., Dawsey, Scott, Gupta, Shilpa, Carril-Ajuria, Lucia, Castellano, Daniel, de Kouchkovsky, Ivan, Jindal, Tanya, Koshkin, Vadim S., Park, Joseph J., Alva, Ajjai, Bilen, Mehmet A., Stewart, Tyler F., McKay, Rana R., Tripathi, Nishita, Agarwal, Neeraj, Vather-Wu, Naomi, Zakharia, Yousef, Morales-Barrera, Rafael, Devitt, Michael E., Cortellini, Alessio, Fulgenzi, Claudia Angela Maria, Pinato, David J., Nelson, Ariel, Hoimes, Christopher J., Gupta, Kavita, Gartrell, Benjamin A., Sankin, Alex, Tripathi, Abhishek, Zakopoulou, Roubini, Bamias, Aristotelis, Murgic, Jure, Fröbe, Ana, Rodriguez-Vida, Alejo, Drakaki, Alexandra, Liu, Sandy, Lu, Eric, Kumar, Vivek, Lorenzo, Giuseppe Di, Joshi, Monika, Isaacsson-Velho, Pedro, Buznego, Lucia Alonso, Duran, Ignacio, Moses, Marcus, Barata, Pedro, Sonpavde, Guru, Wright, Jonathan L., Yu, Evan Y., Montgomery, Robert Bruce, Hsieh, Andrew C., Grivas, Petros, Khaki, Ali Raza

Source: In Clinical Genitourinary Cancer December 2022 20(6):558-567

Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma

Authors: Makrakis, Dimitrios, Talukder, Rafee, Lin, Genevieve Ihsiu, Diamantopoulos, Leonidas N., Dawsey, Scott, Gupta, Shilpa, Carril-Ajuria, Lucia, Castellano, Daniel, de Kouchkovsky, Ivan, Koshkin, Vadim S., Park, Joseph J., Alva, Ajjai, Bilen, Mehmet A., Stewart, Tyler F., McKay, Rana R., Tripathi, Nishita, Agarwal, Neeraj, Vather-Wu, Naomi, Zakharia, Yousef, Morales-Barrera, Rafael, Devitt, Michael E., Cortellini, Alessio, Fulgenzi, Claudia Angela Maria, Pinato, David J., Nelson, Ariel, Hoimes, Christopher J., Gupta, Kavita, Gartrell, Benjamin A., Sankin, Alex, Tripathi, Abhishek, Zakopoulou, Roubini, Bamias, Aristotelis, Murgic, Jure, Fröbe, Ana, Rodriguez-Vida, Alejo, Drakaki, Alexandra, Liu, Sandy, Lu, Eric, Kumar, Vivek, Lorenzo, Giuseppe Di, Joshi, Monika, Isaacsson-Velho, Pedro, Buznego, Lucia Alonso, Duran, Ignacio, Moses, Marcus, Jang, Albert, Barata, Pedro, Sonpavde, Guru, Yu, Evan Y., Montgomery, Robert Bruce, Grivas, Petros, Khaki, Ali Raza

Source: In Clinical Genitourinary Cancer October 2022 20(5):e440-e452

Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer

Authors: Hoimes, Christopher J., Flaig, Thomas W., Milowsky, Matthew I., Friedlander, Terence W., Bilen, Mehmet Asim, Gupta, Shilpa, Srinivas, Sandy, Merchan, Jaime R., McKay, Rana R., Petrylak, Daniel P., Sasse, Carolyn, Moreno, Blanca Homet, Yu, Yao, Carret, Anne-Sophie, Rosenberg, Jonathan E.

Source: Journal of clinical oncology. 41(1):22-31

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100179829773.0x000001&indx=1&recIds=ETOCvdc_100179829773.0x000001

Minding the Bathwater: Fertility and Reproductive Toxicity in the Age of Immuno-Oncology

Authors: Kim, Anne E., Nelson, Ariel, Stimpert, Kyle, Flyckt, Rebecca L., Thirumavalavan, Nannan, Baker, Karen C., Weinmann, Sophia C., Hoimes, Christopher J.

Source: JCO oncology practice. 18(12):815-822

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100177477874.0x000001&indx=1&recIds=ETOCvdc_100177477874.0x000001

Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin

Authors: Talukder, Rafee, Makrakis, Dimitrios, Diamantopoulos, Leonidas N., Carril-Ajuria, Lucia, Castellano, Daniel, De Kouchkovsky, Ivan, Koshkin, Vadim S., Park, Joseph J., Alva, Ajjai, Bilen, Mehmet A., Stewart, Tyler F., McKay, Rana R., Santos, Victor S., Agarwal, Neeraj, Jain, Jayanshu, Zakharia, Yousef, Morales-Barrera, Rafael, Devitt, Michael E., Grant, Michael, Lythgoe, Mark P., Pinato, David J., Nelson, Ariel, Hoimes, Christopher J., Shreck, Evan, Gartrell, Benjamin A., Sankin, Alex, Tripathi, Abhishek, Zakopoulou, Roubini, Bamias, Aristotelis, Murgic, Jure, Fröbe, Ana, Rodriguez-Vida, Alejo, Drakaki, Alexandra, Liu, Sandy, Kumar, Vivek, Lorenzo, Giuseppe Di, Joshi, Monika, Velho, Pedro Isaacsson, Buznego, Lucia Alonso, Duran, Ignacio, Moses, Marcus, Barata, Pedro, Sonpavde, Guru, Yu, Evan Y., Wright, Jonathan L., Grivas, Petros, Khaki, Ali Raza

Source: Clinical genitourinary cancer. 20(2):165-175

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100172783458.0x000001&indx=1&recIds=ETOCvdc_100172783458.0x000001

Association of prior local therapy and outcomes with programmed‐death ligand‐1 inhibitors in advanced urothelial cancer

Authors: Makrakis, Dimitrios, Talukder, Rafee, Diamantopoulos, Leonidas N., Carril‐Ajuria, Lucia, Castellano, Daniel, De Kouchkovsky, Ivan, Koshkin, Vadim S., Park, Joseph J., Alva, Ajjai, Bilen, Mehmet A., Stewart, Tyler F., McKay, Rana R., Santos, Victor S., Agarwal, Neeraj, Jain, Jayanshu, Zakharia, Yousef, Morales‐Barrera, Rafael, Devitt, Michael E., Grant, Michael, Lythgoe, Mark P., Pinato, David J., Nelson, Ariel, Hoimes, Christopher J., Shreck, Evan, Gartrell, Benjamin A., Sankin, Alex, Tripathi, Abhishek, Zakopoulou, Roubini, Bamias, Aristotelis, Murgic, Jure, Fröbe, Ana, Rodriguez‐Vida, Alejo, Drakaki, Alexandra, Liu, Sandy, Kumar, Vivek, Di Lorenzo, Giuseppe, Joshi, Monika, Isaacsson‐Velho, Pedro, Buznego, Lucia Alonso, Duran, Ignacio, Moses, Marcus, Barata, Pedro, Sonpavde, Guru, Yu, Evan Y., Wright, Jonathan L., Grivas, Petros, Khaki, Ali Raza

Source: BJU international. 130(5):592-603

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100169397776.0x000001&indx=1&recIds=ETOCvdc_100169397776.0x000001

A multicenter, open-label phase 1/2 study of TYRA-300 in advanced urothelial carcinoma and other solid tumors with activating FGFR3 alterations (SURF301).

Authors: Hansen, Aaron Richard, Zhang, Alison Yan, Boni, Valentina, Mantia, Charlene, Yu, Evan Y., Weickhardt, Andrew James, Robert, Marie, Gupta, Shilpa, Morales-Barrera, Rafael, Hoimes, Christopher J., Berlin, Jordan, Iyer, Gopa, Millward, Michael, Lihou, Christine Francis, Loriot, Yohan, Pouessel, Damien, Mittal, Kriti, Hill, Andrew Graham, Racca, Fabricio, Tran, Ben

Source: Journal of Clinical Oncology; 2/20/2025 Supplement 5, Vol. 43, pTPS904-TPS904, 242p

Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes

Authors: Esagian, Stepan M., Khaki, Ali Raza, Diamantopoulos, Leonidas N., Carril‐Ajuria, Lucia, Castellano, Daniel, De Kouchkovsky, Ivan, Park, Joseph J., Alva, Ajjai, Bilen, Mehmet A., Stewart, Tyler F., McKay, Rana R., Santos, Victor S., Agarwal, Neeraj, Jain, Jayanshu, Zakharia, Yousef, Morales‐Barrera, Rafael, Devitt, Michael E., Nelson, Ariel, Hoimes, Christopher J., Shreck, Evan, Gartrell, Benjamin A., Sankin, Alex, Tripathi, Abhishek, Zakopoulou, Roubini, Bamias, Aristotelis, Rodriguez‐Vida, Alejo, Drakaki, Alexandra, Liu, Sandy, Kumar, Vivek, Lythgoe, Mark P., Pinato, David J., Murgic, Jure, Fröbe, Ana, Joshi, Monika, Isaacsson Velho, Pedro, Hahn, Noah, Alonso Buznego, Lucia, Duran, Ignacio, Moses, Marcus, Barata, Pedro, Galsky, Matthew D., Sonpavde, Guru, Yu, Evan Y., Msaouel, Pavlos, Koshkin, Vadim S., Grivas, Petros

Source: BJU international. 128(2):196-205

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100124853390.0x000001&indx=1&recIds=ETOCvdc_100124853390.0x000001

Perioperative pembrolizumab therapy in muscle-invasive bladder cancer: Phase III KEYNOTE-866 and KEYNOTE-905/EV-303

Authors: Galsky, Matthew D, Hoimes, Christopher J, Necchi, Andrea, Shore, Neal, Witjes, J Alfred, Steinberg, Gary, Bedke, Jens, Nishiyama, Hiroyuki, Fang, Xiao, Kataria, Ritesh, Sbar, Eric, Jia, Xieyang, Siefker-Radtke, Arlene

Source: Future oncology. 17(24):3137-3150

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100187778318.0x000001&indx=1&recIds=ETOCvdc_100187778318.0x000001

Impact of performance status on treatment outcomes: A real‐world study of advanced urothelial cancer treated with immune checkpoint inhibitors

Authors: Khaki, Ali Raza, Li, Ang, Diamantopoulos, Leonidas N., Bilen, Mehmet A., Santos, Victor, Esther, John, Morales‐Barrera, Rafael, Devitt, Michael, Nelson, Ariel, Hoimes, Christopher J., Shreck, Evan, Assi, Hussein, Gartrell, Benjamin A., Sankin, Alex, Rodriguez‐Vida, Alejo, Lythgoe, Mark, Pinato, David J., Drakaki, Alexandra, Joshi, Monika, Isaacsson Velho, Pedro, Hahn, Noah, Liu, Sandy, Alonso Buznego, Lucia, Duran, Ignacio, Moses, Marcus, Jain, Jayanshu, Murgic, Jure, Baratam, Praneeth, Barata, Pedro, Tripathi, Abhishek, Zakharia, Yousef, Galsky, Matthew D., Sonpavde, Guru, Yu, Evan Y., Shankaran, Veena, Lyman, Gary H., Grivas, Petros

Source: Cancer. 126(6):1208-1216

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100103075859.0x000001&indx=1&recIds=ETOCvdc_100103075859.0x000001

Systemic Therapies for Melanoma Brain Metastases: A Primer for Radiologists

Authors: Dodson, Cassidy, Smith, Daniel A., Richards, Tyler J., Devita, Robert R., Hoimes, Christopher J., Ramaiya, Nikhil H.

Source: Journal of computer assisted tomography. 44(3):346-355

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100181162653.0x000001&indx=1&recIds=ETOCvdc_100181162653.0x000001

Myocarditis associated with immune checkpoint inhibitor therapy: a case report of three patients

Authors: Ansari-Gilani, Kianoush, Tirumani, Sree Harsha, Smith, Daniel A., Nelson, Ariel, Alahmadi, Asrar, Hoimes, Christopher J., Ramaiya, Nikhil H.

Source: Emergency radiology. 27(4):455-460

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100168177619.0x000001&indx=1&recIds=ETOCvdc_100168177619.0x000001

Myeloid-derived suppressors cells (MDSC) correlate with clinicopathologic factors and pathologic complete response (pCR) in patients with urothelial carcinoma (UC) undergoing cystectomy

Authors: Ornstein, Moshe C., Diaz-Montero, Claudia Marcela, Rayman, Patricia, Elson, Paul, Haywood, Samuel, Finke, James H., Kim, Jin S., Pavicic, Paul G., Jr, Lamenza, Marcelo, Devonshire, Sarah, Dann, Priscilla, Schach, Kim, Stephenson, Andrew, Campbell, Steven, Emamekhoo, Hamid, Ernstoff, Marc S., Hoimes, Christopher J., Gilligan, Timothy D., Rini, Brian I., Garcia, Jorge A., Grivas, Petros

Source: In Urologic Oncology: Seminars and Original Investigations September 2018 36(9):405-412

Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab.

Authors: Milowsky, Matthew I., O'Donnell, Peter H., Hoimes, Christopher J., Petrylak, Daniel P., Flaig, Thomas W., Moon, Helen H., Friedlander, Terence W., Mar, Nataliya, McKay, Rana R., Srinivas, Sandy, Gravis, Gwenaelle, Ramamurthy, Chethan, Bupathi, Manojkumar, Bracarda, Sergio, Wright, Phoebe, Hepp, Zsolt, Carret, Anne-Sophie, Yu, Yao, Dillon, Ryan, Kataria, Ritesh

Source: Journal of Clinical Oncology; 4/20/2024, Vol. 42 Issue 12, p1403-1414, 20p

Immune checkpoint-mediated myositis and myasthenia gravis: A case report and review of evaluation and management

Authors: Kang, Kylie H., Grubb, William, Sawlani, Komal, Gibson, Michael K., Hoimes, Christopher J., Rogers, Lisa R., Lavertu, Pierre, Yao, Min

Source: American journal of otolaryngology. 39(5):642-645

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100065952788.0x000001&indx=1&recIds=ETOCvdc_100065952788.0x000001

Racial Disparities in Partial Nephrectomy Persist Across Hospital Types: Results From a Population-based Cohort

Authors: Kiechle, Jonathan E., Abouassaly, Robert, Gross, Cary P., Dong, Shan, Cherullo, Edward E., Zhu, Hui, Trinh, Quoc-Dien, Sun, Maxine, Meropol, Neal J., Hoimes, Christopher J., Ialacci, Sarah, Kim, Simon P. ^*

Source: In Urology April 2016 90:69-75

New phase 1 SURPASS trial cohort: Early-line ADP-A2M4CD8 T-cell receptor T-cell therapy plus pembrolizumab in urothelial carcinoma.

Authors: Aggen, David H, Garcia, Alejandro, Saro Suarez, Jose M, Sauer, Amy, Cristiani, Sebastiano, Brophy, Francine Elizabeth, Streets, Sharon, Norry, Elliot, Nelson, Ariel Ann, Kilari, Deepak, Garmezy, Benjamin, Charlson, John A., Zugazagoitia, Jon, Calvo, Emiliano, Moreno, Irene, Moreno, Victor, Hoimes, Christopher J., Hong, David S., Cervantes, Andres

Source: Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, pTPS708-TPS708, 193p